+91 9891296838 / 9811747774
ONIVYDE is a topoisomerase inhibitor indicated, in combination with fluorouracil and leucovorin, for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy.
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of ONIVYDE (irinotecan liposome injection) brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the ONIVYDE (irinotecan liposome injection) cost price in India.
The order for ONIVYDE (irinotecan liposome injection) will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Irinotecan liposome injection is indicated for use in conjunction with fluorouracil and leucovorin as second-line therapy of metastatic pancreatic cancer that has progressed following gemcitabine-based therapy.
ONIVYDE™ (irinotecan liposome injection), for intravenous use Initial U.S. Approval: 1996
Generic Name: irinotecan liposome
Injection: 43 mg/10 mL single dose vial
60/4 1st Floor, T&T Building, Indian Oil Complex,
Yusuf Sarai, New Delhi, Delhi 110016
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand ONIVYDE (irinotecan liposome injection) on prescription and Import License in Patient's Name only.
For overseas patients, ONIVYDE (irinotecan liposome injection) can be made available in Send your enquiry to find ONIVYDE (irinotecan liposome injection) in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For ONIVYDE (irinotecan liposome injection) Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details
Arm Z1D of NCI-MATCH Shows Promise for Nivolumab Beyond Colorectal Cancer For More Details
Liposomal Irinotecan Active in Small Cell Lung CancerReadMore